New York Life Investment Management LLC Acadia Pharmaceuticals Inc Transaction History

New York Life Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$20.78 - $31.77 $11,179 - $17,092	-538 Reduced 2.85%	18,351 $574,000
Q3 2023 Nov 07, 2023	SELL	$20.84 - $33.47 $62,728 - $100,744	-3,010 Reduced 13.74%	18,889 $393,000
Q2 2023 Aug 04, 2023	SELL	$17.8 - $25.65 $53,239 - $76,719	-2,991 Reduced 12.02%	21,899 $524,000
Q1 2023 May 08, 2023	BUY	$16.32 - $20.92 $23,957 - $30,710	1,468 Added 6.27%	24,890 $468,000
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $37,473 - $49,164	2,639 Added 12.7%	23,422 $372,000
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $21,574 - $27,934	1,529 Added 7.94%	20,783 $340,000
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $250,494 - $524,093	19,254 New	19,254 $271,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.